
Atova EZ10 mg+10 m
Beximco Pharmaceuticals Ltd.
Atorvastatin + Ezetimibe combines a statin (atorvastatin) with a cholesterol absorption inhibitor (ezetimibe) and is used for the following indications: Established / Guideline-Supported Uses As an…
Atorvastatin + Ezetimibe combines a statin (atorvastatin) with a cholesterol absorption inhibitor (ezetimibe) and is used for the following indications:
Atorvastatin + Ezetimibe is not indicated for patients whose predominant abnormality is elevated chylomicrons (elevated triglycerides only, e.g. Fredrickson Type I, III, IV, and V dyslipidemia).
Atorvastatin + Ezetimibe is taken orally, once daily, generally in the evening, with or without food. The dose is individualized based on baseline LDL-cholesterol level, treatment goal, and current statin/ezetimibe therapy, and should be determined by the prescribing physician.
| Indication | Typical Adult Dose |
|---|---|
| Primary hyperlipidemia / mixed dyslipidemia | Starting dose commonly atorvastatin 10 mg/ezetimibe 10 mg once daily; may be adjusted up to atorvastatin 80 mg/ezetimibe 10 mg once daily depending on response and goal, at intervals of no less than 2 weeks between titrations. |
| Patients requiring >55% LDL-C reduction | May be started at a higher combined strength (e.g. atorvastatin 40 mg/ezetimibe 10 mg) under physician supervision. |
| Homozygous familial hypercholesterolemia (adjunct) | Atorvastatin 10–80 mg with ezetimibe 10 mg once daily, as adjunct to other lipid-lowering treatments (e.g. LDL apheresis), under specialist supervision. |
| Concomitant strong CYP3A4 inhibitors or specific interacting drugs | Lower atorvastatin-component doses or avoidance may be required (see Interactions). |
No dose adjustment of the atorvastatin component is generally required for renal impairment; ezetimibe also generally requires no adjustment in mild-to-moderate renal impairment, but Atorvastatin + Ezetimibe should be used with caution and under medical supervision in patients with significant renal disease.
Atorvastatin + Ezetimibe is contraindicated in active liver disease (see Contraindications). Liver function should be assessed before starting and monitored during treatment.
Most patients tolerate Atorvastatin + Ezetimibe well; when side effects occur, they are usually mild. Reported side effects include:
Atorvastatin + Ezetimibe is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.